These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34146408)

  • 1. Thermal treatment enhances the α-glucosidase inhibitory activity of bitter melon (Momordica charantia) by increasing the free form of phenolic compounds and the contents of Maillard reaction products.
    Hsieh HJ; Lin JA; Chen KT; Cheng KC; Hsieh CW
    J Food Sci; 2021 Jul; 86(7):3109-3121. PubMed ID: 34146408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antioxidant properties and quantitative UPLC-MS analysis of phenolic compounds from extracts of fenugreek (Trigonella foenum-graecum) seeds and bitter melon (Momordica charantia) fruit.
    Kenny O; Smyth TJ; Hewage CM; Brunton NP
    Food Chem; 2013 Dec; 141(4):4295-302. PubMed ID: 23993618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolite profiling and in vitro biological activities of two commercial bitter melon (Momordica charantia Linn.) cultivars.
    Perez JL; Jayaprakasha GK; Patil BS
    Food Chem; 2019 Aug; 288():178-186. PubMed ID: 30902279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extraction, quantification, and antioxidant activities of phenolics from pericarp and seeds of bitter melons (Momordica charantia) harvested at three maturity stages (immature, mature, and ripe).
    Horax R; Hettiarachchy N; Chen P
    J Agric Food Chem; 2010 Apr; 58(7):4428-33. PubMed ID: 20225855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NMR-based metabolomic profiling of the differential concentration of phytomedicinal compounds in pericarp, skin and seeds of
    Mishra S; Ankit ; Sharma R; Gogna N; Dorai K
    Nat Prod Res; 2022 Jan; 36(1):390-395. PubMed ID: 33438465
    [No Abstract]   [Full Text] [Related]  

  • 6. Antiglycation and Antioxidant Properties of Momordica charantia.
    Aljohi A; Matou-Nasri S; Ahmed N
    PLoS One; 2016; 11(8):e0159985. PubMed ID: 27513747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase in the free radical scavenging capability of bitter gourd by a heat-drying process.
    Wei L; Shaoyun W; Shutao L; Jianwu Z; Lijing K; Pingfan R
    Food Funct; 2013 Dec; 4(12):1850-5. PubMed ID: 24192975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promise of bitter melon (Momordica charantia) bioactives in cancer prevention and therapy.
    Raina K; Kumar D; Agarwal R
    Semin Cancer Biol; 2016 Oct; 40-41():116-129. PubMed ID: 27452666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo α-amylase and α-glucosidase inhibiting activities of the protein extracts from two varieties of bitter gourd (Momordica charantia L.).
    Poovitha S; Parani M
    BMC Complement Altern Med; 2016 Jul; 16 Suppl 1(Suppl 1):185. PubMed ID: 27454418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of Biological Activities of Wild Bitter Melon (
    Pham TMH; Ngo DH; Ngo DN; Vo TS
    Biomolecules; 2019 May; 9(6):. PubMed ID: 31151277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Momordica charantia extract on insulin resistance and the skeletal muscle GLUT4 protein in fructose-fed rats.
    Shih CC; Lin CH; Lin WL; Wu JB
    J Ethnopharmacol; 2009 May; 123(1):82-90. PubMed ID: 19429344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in silico elucidation of antidiabetic and anti-inflammatory activities of bioactive compounds from Momordica charantia L.
    Shivanagoudra SR; Perera WH; Perez JL; Athrey G; Sun Y; Wu CS; Jayaprakasha GK; Patil BS
    Bioorg Med Chem; 2019 Jul; 27(14):3097-3109. PubMed ID: 31196754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bitter Melon (Momordica charantia) Extract Inhibits Tumorigenicity and Overcomes Cisplatin-Resistance in Ovarian Cancer Cells Through Targeting AMPK Signaling Cascade.
    Yung MM; Ross FA; Hardie DG; Leung TH; Zhan J; Ngan HY; Chan DW
    Integr Cancer Ther; 2016 Sep; 15(3):376-89. PubMed ID: 26487740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bitter melon: a panacea for inflammation and cancer.
    Dandawate PR; Subramaniam D; Padhye SB; Anant S
    Chin J Nat Med; 2016 Feb; 14(2):81-100. PubMed ID: 26968675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Greenhouse-grown bitter melon: production and quality characteristics.
    Tan SP; Parks SE; Stathopoulos CE; Roach PD
    J Sci Food Agric; 2014 Jul; 94(9):1896-903. PubMed ID: 24302224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bitter melon (Momordica charantia): a review of efficacy and safety.
    Basch E; Gabardi S; Ulbricht C
    Am J Health Syst Pharm; 2003 Feb; 60(4):356-9. PubMed ID: 12625217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimized aqueous extraction of saponins from bitter melon for production of a saponin-enriched bitter melon powder.
    Tan SP; Vuong QV; Stathopoulos CE; Parks SE; Roach PD
    J Food Sci; 2014 Jul; 79(7):E1372-81. PubMed ID: 25041538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoglycemic efficacy and safety of Momordica charantia (bitter melon) in patients with type 2 diabetes mellitus.
    Kim SK; Jung J; Jung JH; Yoon N; Kang SS; Roh GS; Hahm JR
    Complement Ther Med; 2020 Aug; 52():102524. PubMed ID: 32951763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracts of Momordica charantia suppress postprandial hyperglycemia in rats.
    Uebanso T; Arai H; Taketani Y; Fukaya M; Yamamoto H; Mizuno A; Uryu K; Hada T; Takeda E
    J Nutr Sci Vitaminol (Tokyo); 2007 Dec; 53(6):482-8. PubMed ID: 18202535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies to improve palatability and increase consumption intentions for Momordica charantia (bitter melon): a vegetable commonly used for diabetes management.
    Snee LS; Nerurkar VR; Dooley DA; Efird JT; Shovic AC; Nerurkar PV
    Nutr J; 2011 Jul; 10():78. PubMed ID: 21794176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.